Erratum: Dysfunction of the stress-responsive FOXC1 transcription factor contributes to the earlier-onset glaucoma observed in Axenfeld-Rieger syndrome patients (Cell Death and Disease (2014) 5 (e1069) DOI:10.1038/cddis.2014.8);Dysfunction of the stress-responsive FOXC1 transcription factor contributes to the earlier-onset glaucoma observed in Axenfeld-Rieger syndrome patients

Cell Death and Disease

Volumn 5, Issue 2, 2014, Pages

  Ito, Y A ^a   Goping, I S ^a   Berry, F ^a   Walter, M A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

axenfeld rieger syndrome; FOXC1; glaucoma; HSPA6; stress response; trabecular meshwork

Indexed keywords

HEAT SHOCK PROTEIN 70; HYDROGEN PEROXIDE; TRANSCRIPTION FACTOR FOXC1;

ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; AXENFELD RIEGER SYNDROME; CELL STRESS; CELL VIABILITY; ENVIRONMENTAL STRESS; EYE DISEASE; HUMAN; MAMMAL CELL; MICROENVIRONMENT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; TRABECULAR MESHWORK;

ANTERIOR EYE SEGMENT; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; EYE ABNORMALITIES; FORKHEAD TRANSCRIPTION FACTORS; GENETIC PREDISPOSITION TO DISEASE; GLAUCOMA; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MUTATION; OXIDANTS; OXIDATIVE STRESS; PHENOTYPE; RNA INTERFERENCE; TRABECULAR MESHWORK; TRANSFECTION;

EID: 84896743838     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.435     Document Type: Erratum

References (46)

1. Rudnicka AR, Mt-Isa S, Owen CG, Cook DG, Ashby D. Variations in primary open-Angle glaucoma prevalence by age, gender, and race: A Bayesian meta-Analysis. Invest Ophthalmol Vis Sci 2006; 10: 4254-4261.
2. Leske MC. Open-Angle glaucoma-An epidemiologic overview. Ophthalmic Epidemiol 2007; 14: 166-172.
3. Shields MB. Axenfeld-Rieger syndrome: A theory of mechanism and distinctions from the iridocorneal endothelial syndrome. Trans Am Ophthalmol Soc 1983; 81: 736-784.
4. Mears AJ, Mirzayans F, Gould DB, Pearce WG, Walter MA. Autosomal dominant iridogoniodysgenesis anomaly maps to 6p25. Am J Hum Genet 1996; 59: 1321-1327.
5. Mears AJ, Jordan T, Mirzayans F, Dubois S, Kume T, Parlee M et al. Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. Am J Hum Genet 1998; 63: 1316-1328.
6. Nishimura DY, Swiderski RE, Alward WL, Searby CC, Patil SR, Bennet SR et al. The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25. Nat Genet 1998; 19: 140-147.
7. Tumer Z, Bach-Holm D. Axenfeld-Rieger syndrome and spectrum of PITX2 and FOXC1 mutations. Eur J Hum Genet 2009; 17: 1527-1539.
8. Saleem RA, Banerjee-Basu S, Berry FB, Baxevanis AD, Walter MA. Analyses of the effects that disease-causing missense mutations have on the structure and function of the wingedhelix protein FOXC1. Am J Hum Genet 2001; 68: 627-641.
9. Ito YA, Footz TK, Murphy TC, Courtens W, Walter MA. Analyses of a novel L130F missense mutation in FOXC1. Arch Ophthalmol 2007; 125: 128-135.
10. Ito YA, Footz TK, Berry FB, Mirzayans F, Yu M, Khan AO et al. Severe molecular defects of a novel FOXC1 W152G mutation result in aniridia. Invest Ophthalmol Vis Sci 2009; 50: 3573-3579.
11. Berry FB, Skarie JM, Mirzayans F, Fortin Y, Hudson TJ, Raymond V et al. FOXC1 is required for cell viability and resistance to oxidative stress in the eye through the transcriptional regulation of FOXO1A. Hum Mol Genet 2008; 17: 490-505.
12. Wang WH, McNatt LG, Shepard AR, Jacobson N, Nishimura DY, Stone EM et al. Optimal procedure for extracting RNA from human ocular tissues and expression profiling of the congenital glaucoma gene FOXC1 using quantitative RT-PCR. Mol Vis 2001; 7: 89-94.
13. Rose RC, Richer SP, Bode AM. Ocular oxidants and antioxidant protection. Proc Soc Exp Biol Med 1998; 217: 397-407.
14. Ramachandran S, Morris SM, Devamanoharan P, Henein M, Varma SD. Radio-isotopic determination of hydrogen peroxide in aqueous humor and urine. Exp Eye Res 1991; 53: 503-506.
15. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
16. Kumar DM, Agarwal N. Oxidative stress in glaucoma: A burden of evidence. J Glaucoma 2007; 16: 334-343.
17. Caballero M, Liton PB, Challa P, Epstein DL, Gonzalez P. Effects of donor age on proteasome activity and senescence in trabecular meshwork cells. Biochem Biophys Res Commun 2004; 323: 1048-1054.
18. de Nadal E, Ammerer G, Posas F. Controlling gene expression in response to stress. Nat Rev Genet 2011; 12: 833-845.
19. Sorkhabi R, Ghorbanihaghjo A, Javadzadeh A, Rashtchizadeh N, Moharrery M. Oxidative DNA damage and total antioxidant status in glaucoma patients. Mol Vis 2011; 17: 41-46.
20. Vittitow J, Borras T. Genes expressed in the human trabecular meshwork during pressureinduced homeostatic response. J Cell Physiol 2004; 201: 126-137.
21. Bradley JM, Kelley MJ, Rose A, Acott TS. Signaling pathways used in trabecular matrix metalloproteinase response to mechanical stretch. Invest Ophthalmol Vis Sci 2003; 44: 5174-5181.
22. Leung TK, Rajendran MY, Monfries C, Hall C, Lim L. The human heat-shock protein family. Expression of a novel heat-inducible HSP70 (HSP70B') and isolation of its cDNA and genomic DNA. Biochem J 1990; 267: 125-132.
23. Noonan E, Giardina C, Hightower L. Hsp70B' and Hsp72 form a complex in stressed human colon cells and each contributes to cytoprotection. Exp Cell Res 2008; 314: 2468-2476.
24. Noonan EJ, Fournier G, Hightower LE. Surface expression of Hsp70B' in response to proteasome inhibition in human colon cells. Cell Stress Chaperones 2008; 13: 105-110.
25. Noonan EJ, Place RF, Rasoulpour RJ, Giardina C, Hightower LE. Cell number-dependent regulation of Hsp70B' expression: Evidence of an extracellular regulator. J Cell Physiol 2007; 210: 201-211.
26. Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2000; 2: 469-475.
27. Kim HE, Jiang X, Du F, Wang X. PHAPI, CAS, and Hsp70 promote apoptosome formation by preventing Apaf-1 aggregation and enhancing nucleotide exchange on Apaf-1. Mol Cell 2008; 30: 239-247.
28. Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol 2000; 2: 476-483.
29. Ravagnan L, Gurbuxani S, Susin SA, Maisse C, Daugas E, Zamzami N et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol 2001; 3: 839-843.
30. Stern S, Dror T, Stolovicki E, Brenner N, Braun E. Genome-wide transcriptional plasticity underlies cellular adaptation to novel challenge. Mol Syst Biol 2007; 3: 106.
31. Kampinga HH, Craig EA. The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nat Rev Mol Cell Biol 2010; 11: 579-592.
32. Akerfelt M, Morimoto RI, Sistonen L. Heat shock factors: Integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol 2010; 11: 545-555.
33. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001; 13: 114-119.
34. Saito K, Dai Y, Ohtsuka K. Enhanced expression of heat shock proteins in gradually dying cells and their release from necrotically dead cells. Exp Cell Res 2005; 310: 229-236.
35. Calderwood SK, Mambula SS, Gray Jr. PJ. Extracellular heat shock proteins in cell signaling and immunity. Ann N Y Acad Sci 2007; 1113: 28-39.
36. Calnan DR, Brunet A. The FoxO code. Oncogene 2008; 27: 2276-2288.
37. Berry FB, Mirzayans F, Walter MA. Regulation of FOXC1 stability and transcriptional activity by an epidermal growth factor-Activated mitogen-Activated protein kinase signaling cascade. J Biol Chem 2006; 281: 10098-10104.
38. Lehmann OJ, Ebenezer ND, Jordan T, Fox M, Ocaka L, Payne A et al. Chromosomal duplication involving the forkhead transcription factor gene FOXC1 causes iris hypoplasia and glaucoma. Am J Hum Genet 2000; 67: 1129-1135.
39. Lehmann OJ, Ebenezer ND, Ekong R, Ocaka L, Mungall AJ, Fraser S et al. Ocular developmental abnormalities and glaucoma associated with interstitial 6p25 duplications and deletions. Invest Ophthalmol Vis Sci 2002; 43: 1843-1849.
40. Nishimura DY, Searby CC, Alward WL,Walton D, Craig JE, Mackey DA et al. A spectrum of FOXC1 mutations suggests gene dosage as a mechanism for developmental defects of the anterior chamber of the eye. Am J Hum Genet 2001; 68: 364-372.
41. Ray PS, Wang J, Qu Y, Sim MS, Shamonki J, Bagaria SP et al. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. Cancer Res 2010; 70: 3870-3876.
42. Tonoki H, Harada N, Shimokawa O, Yosozumi A, Monzaki K, Satoh K et al. Axenfeld-Rieger anomaly and Axenfeld-Rieger syndrome: Clinical, molecular-cytogenetic, and DNA array analyses of three patients with chromosomal defects at 6p25. Am J Med Genet 2011; 155A: 2925-2932.
43. Schwechter BR, Millet LE, Levin LA. Histone deacetylase inhibition-mediated differentiation of RGC-5 cells and interaction with survival. Invest Ophthalmol Vis Sci 2007; 48: 2845-2857.
44. Kozlowski K, Walter MA. Variation in residual PITX2 activity underlies the phenotypic spectrum of anterior segment developmental disorders. Hum Mol Genet 2000; 9: 2131-2139.
45. Huang L, Chi J, Berry FB, Footz TK, Sharp MW, Walter MA. Human p32 is a novel FOXC1-interacting protein that regulates FOXC1 transcriptional activity in ocular cells. Invest Ophthalmol Vis Sci 2008; 49: 5243-5249.
46. Tamimi Y, Skarie JM, Footz T, Berry FB, Link BA, Walter MA. FGF19 is a target for FOXC1 regulation in ciliary body-derived cells. Hum Mol Genet 2006; 15: 3229-3240.